Zonnebodo Pharmaceutical, a Nissha company, is a manufacture and a marketing authorization holder of pharmaceuticals and quasi-drugs. Nissha performs contract development of Oral Thin Films, and Zonnebodo Pharmaceutical plans to provide contract manufacturing of them.

By means of the Core Technologies as well as other innovations, Nissha aims to make a corporate social contribution to the pharmaceutical market, as it has in other markets, in such a way as to enrich people’s lives.

Oral Thin Film is a type of Drug Delivery System (*1), and there are two administration routes: oral administration and mucosal absorption.
Since it is thin-film dosage form and will quicky dissolve in the mouth, Oral Thin Film can be taken easily by patient with difficulty with swallowing, and is expected to ease administration leading to contributing QOL (Quality of Life).

By applying Nissha's Core Technology, our process is expected to improve in yield compared to conventional construction ones (according to our research). Our Oral Thin Film can be applied to various APIs and ingredient and is flexible in shape, so expected breakthrough in dosage form development.

*1: A dosing system designed to optimize operation so that the required volume of drugs is administered to the required part of the body for only the required length of time

Zonnebodo Pharmaceutical has manufacturing license for pharmaceuticals and GMP compliant manufacturing facilities with sophisticated manufacturing technologies and quality control capabilities in relation to a variety of drug forms, such as tablets, liquids and powders.